Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Net Cash Flow (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Net Cash Flow for 5 consecutive years, with $38.6 million as the latest value for Q4 2020.

  • On a quarterly basis, Net Cash Flow rose 5300.81% to $38.6 million in Q4 2020 year-over-year; TTM through Dec 2020 was $51.8 million, a 2595.06% increase, with the full-year FY2024 number at -$14.8 million, down 273.23% from a year prior.
  • Net Cash Flow was $38.6 million for Q4 2020 at Forte Biosciences, up from -$7.6 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $69.2 million in Q2 2017 to a low of -$38.9 million in Q4 2017.
  • A 5-year average of $4.2 million and a median of -$826000.0 in 2016 define the central range for Net Cash Flow.
  • Biggest YoY gain for Net Cash Flow was 14488.82% in 2017; the steepest drop was 4175.71% in 2017.
  • Forte Biosciences' Net Cash Flow stood at -$910000.0 in 2016, then plummeted by 4175.71% to -$38.9 million in 2017, then surged by 144.54% to $17.3 million in 2018, then crashed by 104.28% to -$742000.0 in 2019, then surged by 5300.81% to $38.6 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Net Cash Flow are $38.6 million (Q4 2020), -$7.6 million (Q3 2020), and $10.9 million (Q2 2020).